These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Structure of the type V-C CRISPR-Cas effector enzyme. Kurihara N; Nakagawa R; Hirano H; Okazaki S; Tomita A; Kobayashi K; Kusakizako T; Nishizawa T; Yamashita K; Scott DA; Nishimasu H; Nureki O Mol Cell; 2022 May; 82(10):1865-1877.e4. PubMed ID: 35366394 [TBL] [Abstract][Full Text] [Related]
6. Optimized protocols for the characterization of Cas12a activities. Martin L; Rostami S; Rajan R Methods Enzymol; 2023; 679():97-129. PubMed ID: 36682874 [TBL] [Abstract][Full Text] [Related]
7. Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance. Pausch P; Müller-Esparza H; Gleditzsch D; Altegoer F; Randau L; Bange G Mol Cell; 2017 Aug; 67(4):622-632.e4. PubMed ID: 28781236 [TBL] [Abstract][Full Text] [Related]
10. Mechanistic Insights into the cis- and trans-Acting DNase Activities of Cas12a. Swarts DC; Jinek M Mol Cell; 2019 Feb; 73(3):589-600.e4. PubMed ID: 30639240 [TBL] [Abstract][Full Text] [Related]
11. Miniature type V-F CRISPR-Cas nucleases enable targeted DNA modification in cells. Bigelyte G; Young JK; Karvelis T; Budre K; Zedaveinyte R; Djukanovic V; Van Ginkel E; Paulraj S; Gasior S; Jones S; Feigenbutz L; Clair GS; Barone P; Bohn J; Acharya A; Zastrow-Hayes G; Henkel-Heinecke S; Silanskas A; Seidel R; Siksnys V Nat Commun; 2021 Oct; 12(1):6191. PubMed ID: 34702830 [TBL] [Abstract][Full Text] [Related]
12. Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a. Swarts DC; van der Oost J; Jinek M Mol Cell; 2017 Apr; 66(2):221-233.e4. PubMed ID: 28431230 [TBL] [Abstract][Full Text] [Related]
13. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9. Yang H; Patel DJ Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637 [TBL] [Abstract][Full Text] [Related]
14. Programmable RNA recognition and cleavage by CRISPR/Cas9. O'Connell MR; Oakes BL; Sternberg SH; East-Seletsky A; Kaplan M; Doudna JA Nature; 2014 Dec; 516(7530):263-6. PubMed ID: 25274302 [TBL] [Abstract][Full Text] [Related]
15. Structural Basis for the Inhibition of CRISPR-Cas12a by Anti-CRISPR Proteins. Zhang H; Li Z; Daczkowski CM; Gabel C; Mesecar AD; Chang L Cell Host Microbe; 2019 Jun; 25(6):815-826.e4. PubMed ID: 31155345 [TBL] [Abstract][Full Text] [Related]
16. DNA targeting by subtype I-D CRISPR-Cas shows type I and type III features. Lin J; Fuglsang A; Kjeldsen AL; Sun K; Bhoobalan-Chitty Y; Peng X Nucleic Acids Res; 2020 Oct; 48(18):10470-10478. PubMed ID: 32960267 [TBL] [Abstract][Full Text] [Related]
17. Assembly of Francisella novicida Cpf1 endonuclease in complex with guide RNA and target DNA. Alcón P; Montoya G; Stella S Acta Crystallogr F Struct Biol Commun; 2017 Jul; 73(Pt 7):409-415. PubMed ID: 28695850 [TBL] [Abstract][Full Text] [Related]
18. Mg Son H; Park J; Hwang I; Jung Y; Bae S; Lee S Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34853172 [TBL] [Abstract][Full Text] [Related]